Clonidine extended release - Tris Pharma
At a glance
- Drug Originator Tris Pharma
- Drug Licenced by Athena Bioscience; Pfizer
- Drug Class Analgesics; Anti-inflammatories; Antiglaucomas; Antimigraines; Behavioural disorder therapies; Centrally-acting antihypertensives; Chlorobenzenes; Imidazolines; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Imidazoline receptor agonists
- USA Patent Applicants ATHENA; TRIS PHARMA INC
- USA Patents 10
- NDAs 2
- International Patents 21
- Patent Applications 2,320
Disclaimer